Koss Olinger Consulting LLC Cuts Stock Position in Corteva, Inc. $CTVA

Koss Olinger Consulting LLC lowered its holdings in Corteva, Inc. (NYSE:CTVA) by 22.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,462 shares of the company’s stock after selling 7,210 shares during the period. Koss Olinger Consulting LLC’s holdings in Corteva were worth $1,640,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Norges Bank purchased a new position in Corteva in the fourth quarter worth $504,001,000. Eurizon Capital SGR S.p.A. purchased a new position in Corteva in the fourth quarter worth $47,206,000. Hillsdale Investment Management Inc. lifted its position in shares of Corteva by 9.1% during the 4th quarter. Hillsdale Investment Management Inc. now owns 14,440 shares of the company’s stock valued at $968,000 after buying an additional 1,200 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Corteva during the 4th quarter valued at $460,000. Finally, Basepoint Wealth LLC purchased a new position in shares of Corteva during the 4th quarter valued at $30,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE:CTVA opened at $78.41 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The firm has a market cap of $52.44 billion, a price-to-earnings ratio of 46.12, a PEG ratio of 2.47 and a beta of 0.59. The business’s fifty day moving average is $81.33 and its 200 day moving average is $74.53.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Wolfe Research upped their price target on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Royal Bank Of Canada upped their price target on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Berenberg Bank upped their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Finally, CICC Research upped their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.